A novel nonviral vector based on vesicular stomatitis virus

Journal of Controlled Release

Volumn 68, Issue 2, 2000, Pages 187-194

  Imazu, Susumu ^a   Nakagawa, Shinsaku ^a   Nakanishi, Tsuyoshi ^a   Mizuguchi, Hiroyuki ^b   Uemura, Hidetoshi ^c   Yamada, Osamu ^c   Mayumi, Tadanori ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c Fuso Pharmaceutical Industries Ltd   (Japan)

Author keywords

Fusion product; Liposome; Nonviral vector; Vesicular stomatitis virus; VSV liposome

Indexed keywords

DIPHTHERIA TOXIN; LIPOSOME; PLASMID DNA; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG TRANSPORT; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TECHNIQUE; VESICULAR STOMATITIS VIRUS;

GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LIPOSOMES; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 0034632946     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(00)00250-9     Document Type: Article

References (31)

1. Zhu N., Liggitt D., Liu Y., Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science. 261:1993;209-211.
2. Straubinger R.M., Hong K., Friend D.S., Papahadjopoulos D. Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with a low pH compartment after internalization in coated vesicles. Cell. 32:1983;1069-1079.
3. Cudd A., Nicolau C. Intracellular fate of liposome-encapsulated DNA in mouse liver. Analysis using electron microscope autoradiography and subcellular fractionation. Biochim. Biophys. Acta. 845:1985;477-491.
4. Zabner J., Fasbender A.J., Moninger T., Poellinger K.A., Welsh M.J. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270:1995;18997-19007.
5. Dales S. Early events in cell-animal virus interactions. Bacteriol. Rev. 37:1973;103-135.
6. Matlin K.S., Reggio H., Helenius A., Simons K. Pathway of vesicular stomatitis virus entry leading to infection. J. Mol. Biol. 156:1982;609-631.
7. Schlegel R., Dickson R.B., Willingham M.C., Pastam I.H. Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of alpha 2-macroglobulin. Proc. Natl. Acad. Sci. USA. 79:1982;2291-2295.
8. Wehland J., Willingham M.C., Gallo M.G., Pastan I. The morphologic pathway of exocytosis of the vesicular stomatitis virus G protein in cultured fibroblasts. Cell. 28:1982;831-841.
9. Helenius A., Mellman I., Wall D., Hubbard A. Endasomes. Trends Biochem. Sci. 8:1983;245-250.
10. Pastan I., Willingham M.C. Receptor-mediated endocytosis, coated pits, receptosomes and the golgi. Trends Biochem. Sci. 8:1983;250-254.
11. Cartwright B., Smale C.J., Brown F. Surface structure of vesicular stomatitis virus. J. Gen. Virol. 5:1969;1-10.
12. Schloemer R.H., Wagner R.R. Sialoglycoprotein of vesicular stomatitis virus: role of the neuraminic acid in infection. J. Virol. 14:1974;270-281.
13. Schloemer R.H., Wagner R.R. Cellular adsorption function of the sialoglycoprotein of vesicular stomatitis virus and its neuraminic acid. J. Virol. 15:1975;882-893.
14. Kelley J.M., Emerson S.U., Wagner R.R. The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. J. Virol. 10:1972;1231-1235.
15. White J., Matlin K., Helenius A. Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J. Cell Biol. 89:1981;674-679.
16. Metsikko K., van Meer G., Simmons K. Reconstitution of the fusogenic activity of vesicular stomatitis virus. EMBO J. 5:1986;3429-3435.
17. Paternostre M., Lowy R.J., Blumental R. pH-dependent fusion of reconstituted vesicular stomatitis virus envelopes with Vero cells. Measurement by dequenching of fluorescence. FEBS Lett. 243:1989;251-258.
18. Hug P., Sleight R.G. Fusogenic virosomes prepared by partitioning of vesicular stomatitis virus G protein into preformed vesicles. J. Biol. Chem. 269:1994;4050-4056.
19. Vainstein A., Hershkovitz M., Israel S., Rabin S., Loyter A. A new method for reconstitution of highly fusogenic Sendai virus envelopes. Biochim. Biophys. Acta. 773:1984;181-188.
20. Oku N., A Kendall D., MacDonald R.C. A simple procedure for the determination of the trapped volume of liposomes. Biochim. Biophys. Acta. 691:1982;332-340.
21. Mizuguchi H., Nakagawa T., Nakanishi M., Imazu S., Nakagawa S., Mayumi T. Efficient gene transfer into mammalian cells using fusogenic liposome. Biochem. Biophys. Res. Commun. 218:1996;402-407.
22. Struck D.K., Hoekstra D., Pagano R.E. Use of resonance energy transfer to monitor membrane fusion. Biochemistry. 20:1981;4093-4099.
23. Yamaizumi M., Mekada E., Uchida T., Okada Y. One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell. 15:1978;245-250.
24. Larsen C.E., Nir S., Alford D.R., Jennings M., Lee K.D., Duzgunes N. Human immunodeficiency virus type 1 (HIV-1) fusion with model membranes: kinetic analysis and the role of lipid composition, pH and divalent cations. Biochim. Biophys. Acta. 1147:1993;223-236.
25. Maeda T., Kawasaki K., Ohnishi S. Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2. Proc. Natl. Acad. Sci. USA. 78:1981;4133-4137.
26. Nakanishi M., Uchida T., Sugawa H., Ishiura M., Okada Y. Efficient introduction of contents of liposomes into cells using HVJ (Sendai virus). Exp. Cell Res. 159:1985;399-409.
27. Mizuguchi H., Nakanishi T., Kondoh M., Nakagawa T., Nakanishi M., Matsuyama T., Tsutsumi Y., Nakagawa S., Mayumi T. Fusion of sendai virus with liposome depends on only F protein, but not HN protein. Virus Res. 59:1999;191-201.
28. White J., Helenius A. pH-dependent fusion between the Semliki Forest virus membrane and liposomes. Proc. Natl. Acad. Sci. USA. 77:1980;3273-3277.
29. Mizuguchi H., Nakanishi M., Nakanishi T., Nakagawa T., Nakagawa S., Mayumi T. Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy. Br. J. Cancer. 73:1996;472-476.
30. Mizuguchi H., Nakanishi T., Nakanishi M., Nakagawa T., Nakagawa S., Mayumi T. Intratumor administration of fusogenic liposomes containing fragment A of diphtheria toxin suppresses tumor growth. Cancer Lett. 100:1996;63-69.
31. Mizuguchi H., Nakagawa T., Toyosawa S., Nakanishi M., Imazu S., Nakanishi T., Tsutsumi Y., Nakagawa S., Hayakawa T., Ijuhin N., Mayumi T. Tumor necrosis factor alpha-mediated tumor regression by the in vivo transfer of genes into the artery that leads to tumors. Cancer Res. 58:1998;5725-5730.